title: The early marginal zone B cell-initiated T-independent type 2 response resists the proteasome inhibitor bortezomib.
authors.affiliation: Department of Internal Medicine 3, University of Erlangen–Nuremberg, Erlangen, Germany.
authors.forename: Veronika R
authors.initials: VR
authors.lastname: Lang
authors.forename: Dirk
authors.initials: D
authors.lastname: Mielenz
authors.forename: Kirsten
authors.initials: K
authors.lastname: Neubert
authors.forename: Christina
authors.initials: C
authors.lastname: Böhm
authors.forename: Georg
authors.initials: G
authors.lastname: Schett
authors.forename: Hans-Martin
authors.initials: HM
authors.lastname: Jäck
authors.forename: Reinhard E
authors.initials: RE
authors.lastname: Voll
authors.forename: Silke
authors.initials: S
authors.lastname: Meister